Belgium· BE-AMP-SAM000131-00

Endoxan 50 mg

A cyclophosphamide product containing cyclophosphamide, registered in Belgium by Baxter. The same ATC class is registered in 17 of our 19 countries.

ATC L01AA01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cyclophosphamideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cyclophosphamide is registered in 17 of 19 countries.

Countries holding a registration under ATC L01AA01 (cyclophosphamide), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search cyclophosphamide products by name

Cyclophosphamide · ATC L01AA01

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cyclophosphamide costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), the median price runs from $1.57 in France to $14.12 in Switzerland — a ×9.0 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cyclophosphamide · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

CH Switzerland$14.12
IT Italy$1.58
FR France$1.57

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Cyclophosphamide
Manufacturer: Baxter
Country: Belgium (BE)
ATC code: L01AA01
ATC class: Cyclophosphamide
Defined daily dose: 0.25 g, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

1 priced

be_apb
0110882
EUR 18.61
be_apb
0706242

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

541 interactions on record for cyclophosphamide.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cyclophosphamide against other medicines How interaction checks work

Cyclophosphamide · interactions on record

541 records

34 severe
172 moderate
29 minor
304 info

Most severe, free to view

Nalidixic acidJ01MB02severe
CidofovirJ05AB12severe
ThiotepaL01AC01severe
CladribineL01BB04severe

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclophosphamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclophosphamide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Cyclophosphamid Sandoz, Endoxan
Bulgaria · Cyclophosphamide Sandoz, Ендоксан
Cyprus · Cyclophosphamide Accord, Endoxan
Czechia · Cyclophosphamide Accord, Endoxan
Germany · Cyclophosphamid Accord, Cyclophosphamid Beta
Denmark · Cyclophosphamide Accord, Cyclophosphamide Sandoz
Estonia · Cyclophosphamide Accord, Endoxan
Spain · Ciclofosfamida Accord, Ciclofosfamida Dr. Reddy
Finland · Cyclophosphamide Accord, Sendoxan
France · Cyclophosphamide Accord, Cyclophosphamide Reddy Pharma
United Kingdom (Northern Ireland) · Cyclophosphamide Accord Healthcare, Cyclophosphamide Accord-Uk
Greece · Endoxan
Croatia · Ciklofosfamid Accord, Endoxan
Hungary · Endoxan
Ireland · Cyclophosphamide Monohydrate Seacross, Endoxana
Iceland · Sendoxan
Italy · Ciclofosfamide Accord, Cyclophosphamide Monohydrate Seacross
Lithuania · Cyclophosphamide Accord Healthcare, Endoxan
Luxembourg · Endoxan
Latvia · Cyclophosphamide Accord, Endoxan
Malta · Endoxana, Endoxana Injection
Netherlands · Cyclofosfamide Accord, Cyclofosfamide Hikma
Norway · Cyclophosphamide Accord, Sendoxan
Poland · Cyclophosphamide Accord, Cyclophosphamide Sandoz
Portugal · Ciclofosfamida Accord, Ciclofosfamida Hikma
Romania · Ciclofosfamidă Accord, Ciclofosfamidă Dr. Reddy’s
Sweden · Cyclophosphamide Accord, Cyclophosphamide Sandoz
Slovenia · Endoxan
Slovakia · Endoxan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/6747848b-7069-4878-9a59-11b3cfa58b06
GET /v1/drugs/6747848b-7069-4878-9a59-11b3cfa58b06?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Endoxan 50 mg",
  "name_fr": "Endoxan 50 mg",
  "name_nl": "Endoxan 50 mg",
  "amp_code": "SAM000131-00",
  "strengths": [
    "0.6150",
    "24.6000",
    "51.1100",
    "0.1900"
  ],
  "pack_count": 1,
  "substances": [
    "Cyclophosphamide",
    "Glycerol",
    "Lactose",
    "Sucrose",
    "Polysorbate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cyclophosphamide",
  "authorisation_numbers": [
    "BE000131"
  ]
}

API reference MCP server Plans

See everything about cyclophosphamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console